Catatonia: Resurgence of a concept. A review of the international literature;La catatonie: Résurgence d'un concept une revue de la littérature internationale

Encephale

Volumn 28, Issue 6 I, 2002, Pages 481-492

  Pommepuy, N ^a   Januel, D ^a  

^a NONE

Author keywords

Benzodiazepines; Catatonia; ECT; Mood Disorders; Neuroleptics; Schizophrenia

Indexed keywords

LORAZEPAM;

ARTICLE; AUTONOMIC NEUROPATHY; BASAL GANGLION; BRAIN STEM; CATALEPSY; CATATONIA; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DEFENSE MECHANISM; DEMENTIA; DIAPHORESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; FRONTAL LOBE; GESTURE; HUMAN; HYPERACTIVITY; HYPERTHERMIA; HYPOKINESIA; IMMOBILIZATION; IMPULSIVENESS; MESOLIMBIC DOPAMINERGIC SYSTEM; MOOD DISORDER; MORTALITY; MOTOR DYSFUNCTION; PASSIVE MOVEMENT; PREVALENCE; PSYCHOSOCIAL WITHDRAWAL; RIGIDITY; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; STEREOTYPY; STUPOR; SYMPTOMATOLOGY;

EID: 0036875160     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. ABRAMS R, TAYLOR MA. CATATONIA: a prospective clinical study. Arch Gen Psychiatry 1976; 33: 579-81.
2. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of mental disorders. 4 th ed. Washington DC: American Psychiatric Association, 1994.
3. BARNES MP, SAUNDERS M, WALLS TJ. The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry 1986; 49: 991-6.
4. BENEGAL V, HINGORANI S, KHANNA S. Idiopathic catatonia: validity of the concept. Psychopathology 1993; 26: 41-6.
5. BLEULER E. Démence Précoce ou groupe des Schizophrénies (trad Viallard A). Paris: EPEL, 1998.
6. BLUMER D. Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings. Compr Psychiatry 1997; 38: 193-201.
7. BOITEUX J, ROUBAUD L, GANDELET N et al. La place de l'électroconvulsivothérapie. Encephale 1997 (suppl 3): 21-6.
8. BOUCHARD LP, LLORCA PM, WOLF MA. Hypothèses actuelles sur le mécanisme d'action centrale des benzodiazépines. Rev Can Psychiatry 1991; 36: 660-5.
9. BRÄUNIG P, KRUGER S, SHUGAR G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry 1998; 39: 35-46.
10. BRÄUNIG P, KRÜGER S, SHUGAR G et al. The catatonia rating scale I: development, reliability, and use. Compr Psychiatry 2000; 41: 147-58.
11. BUSH G, FINK M, PETRIDES G et al. Catatonia I: rating scale and standardized examination. Acta Psychiatr Scand 1996; 93: 129-36.
12. BUSH G, FINK M, PETRIDES G et al. Catatonia II: treatment with lorazepam and electro-convulsive therapy. Acta Psychiatr Scand 1996: 93: 137-43.
13. BUSH G, PETRIDES G, FRANCIS A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res 1997; 27: 83-92.
14. CAROLL BT, ANFINSON TJ, KENNEDY JC et al. Catatonic disorder due to general medical conditions. J Neuropsychiatr Neurosci 1994; 6: 122-30.
15. CAROLL BT, BOUTROS NN. Clinical electroencephalograms in patients with catatonic disorders. Clin Electroencephalogr 1995; 26: 60-4.
16. CAROLL BT. GABAa versus GABAb hypothesis of catatonia. Mov Disord 1999; 14: 702-3.
17. CERNOVSKY ZZ, LANDMARK JA, MERSKEY H et al. The relationship of catatonia symptoms to symptoms of schizophrenia. Can J Psychiatry 1998; 43: 1031-5.
18. CLARK T, RICKARDS H. Catatonia 2: Diagnosis, management and prognosis. Hosp Med 1999; 60(11): 812-4.
19. COHEN D, FLAMENT M, DUBOS PF et al. Case series: catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry 1999; 38: 1040-6.
20. DELAY J, PICHOT P, LEMPÉRIÈRE TH et al. Un neuroleptique majeur non phénothiazine et non réserpinique, l'halopéridol, dans le traitement des psychoses. Ann Med Psychol 1960; 118: 145-52.
21. DENIKER P, LEMPÉRIÈRE TH, GUYOTAT J. Précis de psychiatrie clinique de l'adulte. Paris: Masson, 1990.
22. EY H. Études Psychiatriques. Paris; Desclée de Brouwer, 1950; 2: 69-162.
23. e éd. 1989. Paris; Masson, 1960.
24. FEIN S, McGRATH MG. Problems in diagnosing bipolar disorder in catatonic patients. J Clin Psychiatry 1990; 51: 203-5.
25. FINK M. Catatonia in DSM IV. Biol Psychiatry 1994; 36: 431-33.
26. FISH F. An outline of psychiatry. Bristol, England; Wright & Sons Ltd, 1964: 56-60.
27. FRANCIS A, DIVADEENAM KM, PETRIDES G. Advances in the diagnosis and treatment of catatonia. Convuls Ther 1996; 12: 259-61.
28. FRANCIS A, DIVADEENAM KM, BUSH G. Consistency of symptoms in recurrent catatonia. Compr Psychiatry 1997; 38: 56-60.
29. GELENBERG AJ. The catatonic syndrome. Lancet 1976; 1: 1339-41.
30. GELENBERG AJ, MANDEL MR. Catatonic reaction to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977; 34: 947-50.
31. GRISARU N, YAROVSLAVSKY U, ABARBANEL J et al. Transcranial magnetic stimulation in depression and schizophrenia. Poster Session. In: Abstracts of VIIth Congress of European College of Neuropsychopharmacology 1994.
32. GRISARU N, CHUDAKOV B, YAROSLAVSKY Y et al. Catatonia treated with transcranial magnetic stimulation. Am J Psychiatry 1998; 155: 1630.
33. GUELFI JD, BOYER P, CONSOLI S et al. Psychiatrie. Paris; PUF, 1987.
34. GUGGENHEIM FG, BABIGIAN HM. Catatonic schizophrenia: epidemiology and clinical course. J Nerv Ment Dis 1974; 158: 291-305.
35. HEARST ED, MUNOZ RA, TUASON VB. Catatonia: its diagnostic validity. Dis Nerv Syst 1971; 32: 453-6.
36. HUANG TL, REE SC, HUANG YC et al. Catatonic features: differential diagnosis and treatment at an emergency unit. Psychiatry Clin Neurosci 1999; 53: 63-6.
37. JASPERS K. Psychopathologie générale (trad Kastler A, Mendousse J). Paris: Claude Tchou, 2000.
38. JOHNSON J. Catatonia: the tension insanity. Br J Psychiatry 1993; 162: 733-38.
39. JOSEPH R. Frontal lobe psychopathology: mania, depression, confabulation, catatonia, perseveration, obsessive compulsions, and schizophrenia. Psychiatry 1999; 62: 138-72.
40. KAHLBAUM KL. La catatonie ou folie tonique (trad Viallard A). Evol Psychiatr 1987; 52(2): 370.
41. KIRBY GH. The catatonic syndrome and its relation to manic-depressive insanity. J Nerv Ment Dis 1913; 40: 694-704.
42. KLEIST K. Schizophrenic symptoms and cerebral pathology. J Ment Sci 1960; 106: 246-55.
43. KOEK RJ, RANDY MERVIS J. Treatment-refractory catatonia, ECT, and parenteral lorazepam. Am J Psychiatry 1999; 156: 160-1.
44. KOUPERNIK C, LOÔ H, ZARIFIAN E. Précis de Psychiatrie. Paris: Flammarion, 1982: 96-100 et 154-62.
45. KRAEPELIN E. Leçons cliniques sur la démence précoce et la psychose maniaco-dépressive. Paris: L'Harmattan, 1998: 29-84.
46. LEE JW, SCHWARTZ DL, HALLMAYER J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 2000; 12: 89-96.
47. LOHR JB, WISNIEWSKI AA. Movement Disorders: a Neuro-psychiatric Approach. New York: Guilford, 1987.
48. LUND C, MORTIMER A, ROGERS D et al. Motor, volitional and behavioral disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale. Br J Psychiatry 1991; 158: 323-7.
49. MAHENDRA B. Where have all the catatonics gone ? Psychol Med 1981; 11: 669-71.
50. MALUR C, PASOL E, FRANCIS A. ECT for prolonged catatonia. J ECT 2001; 17: 55-9.
51. MANN SC, CAROFF SN, BLEIER HR et al. Lethal catatonia. Am J Psychiatry 1986; 143: 1374-81.
52. MANN SC, CAROFF SN, BLEIER HR et al. Electro-convulsive therapy of the lethal catatonia syndrome. Convuls Ther 1990; 6: 239-47.
53. MASTAIN B, VAIVA G, GUEROUANOU D et al. Effet favorable du zolpidem sur un état catatonique. Rev Neurol 1995; 151: 52-6.
54. MASTAIN B, RASCLE C, THOMAS P et al. Zolpidem in catatonic syndrome: from a pharmacological test to a pathophysiological hypothesis. Mov Dis 1998; 13 (suppl 2): 46.
55. McCALL WV, SHELP FE, MCDONALD WM. Controlled investigation of the amobarbital interview for catatonic mutism. Am J Psychiatry 1992; 149: 202-6.
56. McKENNA PJ, LUND CE, MORTIMER AM et al. Motor, volitional and behavioral disorders in schizophrenia. 2: The 'conflict of paradigms'hypothesis. Br J Psychiatry 1991; 158: 328-36.
57. MORRISON JR. Catatonia: retarded and excited types. Arch Gen Psychiatry 1973; 28: 39-41.
58. NORTHOFF G, KOCH A, WENKE J et al. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord 1999; 14: 404-16.
59. OULIS P, LYKOURAS L. Prevalence and diagnostic correlates of DSM IV catatonic features among psychiatric inpatients. J Nerv Ment Dis 1996; 184: 378-9.
60. PATAKI J, ZERVAIS IM, JANDORF L. Catatonia in a university inpatient service (1985-1990). Convuls Ther 1992; 8: 163-73.
61. PERALTA V, CUESTA MJ, SERRANO JF et al. The Kahlbaum syndrome: a study of its clinical validity, nosological status, and relationship with schizophrenia and mood disorder. Compr Psychiatry 1997; 38: 61-7.
62. PERALTA V, CUESTA MJ. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr Res 2001; 47: 117-26.
63. PERALTA V, CUESTA MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res 2001; 47: 107-16.
64. PETRIDES G, DIVADEENAM KM, BUSH G et al. Synergism of lorazepam and electro-convulsive therapy in the treatment of catatonia. Biol Psychiatry 1997; 42: 375-81.
65. PHILBRICK KL, RUMMANS TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994; 6: 1-13.
66. RANKLE HW, RANKELLE. Carbamazepine in the treatment of catatonia. Am J Psychiatry 1988; 145: 361-2.
67. RIES RK. DSM III implications of the diagnoses of catatonia and bipolar disorders. Am J Psychiatry 1985; 142: 1471-4.
68. RIPLEY TL, MILLSON RC. Psychogenic catatonia treated with lorazepam. Am J Psychiatry 1988; 145: 764-5.
69. ROHLAND BM, CAROLL BT, JACOBY RG. ECT in the treatment of catatonic syndrome. J Aff Disord 1993; 29: 255-61.
70. ROSEBUSH PI, HILDEBRAND AM, FURLONG BG et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990; 51: 357-62.
71. SALAM SA, PILLAI AK, BERESFORD TP. Lorazepam for psychogenic catatonia. Am J Psychiatry 1987; 144: 1082-3.
72. SCHMIDER J, STANDHART H, DEUSCHLE M et al. A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biol Psychiatry 1999; 46: 437-441.
73. SMITH M, LEBEGUE B. Lorazepam in the treatment of catatonia. Am J Psychiatry 1991; 148: 1265.
74. STARKSTEIN SE, PETRACCA G, TESON A et al. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry 1996; 60: 326-32.
75. TAYLOR MA, ABRAMS R. Catatonia: prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977; 34: 1223-5.
76. TAYLOR MA. Catatonia: a review of the behavioral neurologic syndrome. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3: 48-72.
77. TRIBOLET S, SHAHIDI M. Précis de sémiologie des troubles psychiques. Thoiry: Heures de France, 2000.
78. UNGVARI GS, CHIU HF, CHOW LY et al. Lorazepam for chronic catatonia: a double-blind, placebo-controlled cross-over study. Psychopharmacologia (Berl) 1999; 142: 393-8.
79. UNGVARI GS, LEUNG HC, WONG M et al. Benzodiazepines in the treatment of the catatonic syndrome. Acta Psychiatr Scand 1994; 89: 285-8.
80. UNGVARI GS, LEUNG HC, LEE TS. Benzodiazepines and the psychopathology of catatonia. Pharmacopsychiatry 1994; 27: 242-5.
81. VEDY P, SAMUELIAN JC, THIRION X. Catatonies et syndromes malins: questions diagnostiques. Synapse 1996; n° 122: 19-25.
82. WHITE DAC, ROBINS AH. Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991; 158: 419-21.
83. WILCOX JA, NASRALLAH HA. Organic factors in catatonia. Br J Psychiatry 1986; 149: 782-4.
84. WORLD HEALTH ORGANIZATION. The ICD-10 Classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
85. YASSA R, ISKANDAR H, LALINEC M et al. Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial. J Clin Psychopharmacol 1990; 10: 66-8.
86. YEUNG P, MILSTEIN R, DANIELS D et al. ECT for lorazepam refractory catatonia. Convuls Ther 1996; 12: 31-5.